- Home
- BMRN vs TTEK Comparison
BMRN vs TTEK Comparison
Compare BMRN & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- TTEK
- Stock Information
- Founded
- BMRN 1996
- TTEK 1966
- Country
- BMRN United States
- TTEK United States
- Employees
- BMRN N/A
- TTEK N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- TTEK Military/Government/Technical
- Sector
- BMRN Health Care
- TTEK Consumer Discretionary
- Exchange
- BMRN Nasdaq
- TTEK Nasdaq
- Market Cap
- BMRN 11.1B
- TTEK 9.4B
- IPO Year
- BMRN 1999
- TTEK 1991
- Fundamental
- Price
- BMRN $54.09
- TTEK $36.14
- Analyst Decision
- BMRN Buy
- TTEK Buy
- Analyst Count
- BMRN 24
- TTEK 5
- Target Price
- BMRN $91.70
- TTEK $42.25
- AVG Volume (30 Days)
- BMRN 1.8M
- TTEK 2.0M
- Earning Date
- BMRN 10-28-2025
- TTEK 11-12-2025
- Dividend Yield
- BMRN N/A
- TTEK 0.72%
- EPS Growth
- BMRN 154.69
- TTEK N/A
- EPS
- BMRN 3.40
- TTEK 0.80
- Revenue
- BMRN $3,063,608,000.00
- TTEK $4,598,536,000.00
- Revenue This Year
- BMRN $13.32
- TTEK $6.67
- Revenue Next Year
- BMRN $9.37
- TTEK N/A
- P/E Ratio
- BMRN $15.91
- TTEK $45.08
- Revenue Growth
- BMRN 18.36
- TTEK 8.59
- 52 Week Low
- BMRN $52.93
- TTEK $27.27
- 52 Week High
- BMRN $85.00
- TTEK $51.20
- Technical
- Relative Strength Index (RSI)
- BMRN 37.63
- TTEK 48.94
- Support Level
- BMRN $55.99
- TTEK $34.67
- Resistance Level
- BMRN $59.79
- TTEK $36.28
- Average True Range (ATR)
- BMRN 1.57
- TTEK 0.74
- MACD
- BMRN -0.40
- TTEK -0.01
- Stochastic Oscillator
- BMRN 0.70
- TTEK 58.80
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About TTEK Tetra Tech Inc.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.